JP2007513998A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007513998A5 JP2007513998A5 JP2006545371A JP2006545371A JP2007513998A5 JP 2007513998 A5 JP2007513998 A5 JP 2007513998A5 JP 2006545371 A JP2006545371 A JP 2006545371A JP 2006545371 A JP2006545371 A JP 2006545371A JP 2007513998 A5 JP2007513998 A5 JP 2007513998A5
- Authority
- JP
- Japan
- Prior art keywords
- nhso
- alkyl
- snr
- nhcor
- conhr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52957303P | 2003-12-16 | 2003-12-16 | |
| PCT/US2004/042097 WO2005060647A2 (en) | 2003-12-16 | 2004-12-16 | Prodrugs of selective androgen receptor modulators and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007513998A JP2007513998A (ja) | 2007-05-31 |
| JP2007513998A5 true JP2007513998A5 (https=) | 2008-02-07 |
Family
ID=34710133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006545371A Pending JP2007513998A (ja) | 2003-12-16 | 2004-12-16 | 選択的アンドロゲン受容体調節剤のプロドラッグ及びその使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7595402B2 (https=) |
| EP (1) | EP1631540A4 (https=) |
| JP (1) | JP2007513998A (https=) |
| KR (1) | KR20060115325A (https=) |
| CN (1) | CN1805921A (https=) |
| AU (2) | AU2004305061A1 (https=) |
| CA (1) | CA2522874A1 (https=) |
| EA (1) | EA200501761A1 (https=) |
| IL (1) | IL172042A0 (https=) |
| MX (1) | MXPA06000119A (https=) |
| TW (1) | TW200533636A (https=) |
| WO (1) | WO2005060647A2 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090264534A1 (en) * | 1996-11-27 | 2009-10-22 | Dalton James T | Selective androgen receptor modulators |
| US7759520B2 (en) | 1996-11-27 | 2010-07-20 | University Of Tennessee Research Foundation | Synthesis of selective androgen receptor modulators |
| US8445534B2 (en) | 2000-08-24 | 2013-05-21 | University Of Tennessee Research Foundation | Treating androgen decline in aging male (ADAM)-associated conditions with SARMs |
| US20040260108A1 (en) * | 2001-06-25 | 2004-12-23 | Dalton James T. | Metabolites of selective androgen receptor modulators and methods of use thereof |
| US7622503B2 (en) | 2000-08-24 | 2009-11-24 | University Of Tennessee Research Foundation | Selective androgen receptor modulators and methods of use thereof |
| US8853266B2 (en) | 2001-12-06 | 2014-10-07 | University Of Tennessee Research Foundation | Selective androgen receptor modulators for treating diabetes |
| US8309603B2 (en) | 2004-06-07 | 2012-11-13 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
| US9889110B2 (en) | 2004-06-07 | 2018-02-13 | University Of Tennessee Research Foundation | Selective androgen receptor modulator for treating hormone-related conditions |
| US9884038B2 (en) | 2004-06-07 | 2018-02-06 | University Of Tennessee Research Foundation | Selective androgen receptor modulator and methods of use thereof |
| ATE552235T1 (de) * | 2004-06-07 | 2012-04-15 | Univ Tennessee Res Foundation | Selektive androgen-rezeptor-modulator und anwendungsverfahren dafür |
| US9844528B2 (en) | 2006-08-24 | 2017-12-19 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
| US9730908B2 (en) | 2006-08-24 | 2017-08-15 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
| US7968603B2 (en) | 2007-09-11 | 2011-06-28 | University Of Tennessee Research Foundation | Solid forms of selective androgen receptor modulators |
| CN103002737A (zh) | 2010-01-11 | 2013-03-27 | Gtx公司 | 治疗睑板腺功能障碍的方法 |
| US10987334B2 (en) | 2012-07-13 | 2021-04-27 | University Of Tennessee Research Foundation | Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs) |
| US10258596B2 (en) | 2012-07-13 | 2019-04-16 | Gtx, Inc. | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) |
| US9969683B2 (en) | 2012-07-13 | 2018-05-15 | Gtx, Inc. | Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS) |
| PT2872482T (pt) | 2012-07-13 | 2020-09-22 | Oncternal Therapeutics Inc | Método de tratamento de cancro de mama com modulador seletivo do recetor de andrógeno (sarm) |
| US9622992B2 (en) | 2012-07-13 | 2017-04-18 | Gtx, Inc. | Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) |
| US10314807B2 (en) | 2012-07-13 | 2019-06-11 | Gtx, Inc. | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) |
| US9744149B2 (en) | 2012-07-13 | 2017-08-29 | Gtx, Inc. | Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) |
| FI130262B (en) * | 2019-08-30 | 2023-05-17 | Medicortex Finland Oy | Formulations and compositions for use in the prevention or treatment of brain injury and neurodegenerative diseases |
| US20230172897A1 (en) * | 2021-12-02 | 2023-06-08 | Veru, Inc. | Methods of treating breast cancers with selective androgen receptor modulators and additional therapeutic agents |
| WO2025102293A1 (zh) * | 2023-11-16 | 2025-05-22 | 北京脑科学与类脑研究所 | 神经活性雄激素受体调节剂及其用途 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3875229A (en) | 1972-11-24 | 1975-04-01 | Schering Corp | Substituted carboxanilides |
| JPS6044294B2 (ja) | 1976-04-15 | 1985-10-02 | 帝国臓器製薬株式会社 | アニリド誘導体 |
| US4139638A (en) | 1976-09-23 | 1979-02-13 | Schering Corporation | Methods for the treatment of hirsutism |
| EP0002309B1 (en) | 1977-10-12 | 1982-12-01 | Imperial Chemical Industries Plc | Acylanilides, process for their manufacture and pharmaceutical and veterinary compositions containing them |
| US4191775A (en) | 1977-12-15 | 1980-03-04 | Imperial Chemical Industries Limited | Amide derivatives |
| NZ197008A (en) | 1980-05-22 | 1984-10-19 | Ici Ltd | Acylanilide derivatives and pharmaceutical compositions |
| JPS57171904A (en) | 1981-04-15 | 1982-10-22 | Mitsubishi Petrochem Co Ltd | Tri- or tetra-substituted phenoxycarboxylic acid anilide type herbicide |
| EP0100172B1 (en) | 1982-07-23 | 1987-08-12 | Imperial Chemical Industries Plc | Amide derivatives |
| US4633025A (en) | 1985-04-15 | 1986-12-30 | Miles Laboratories, Inc. | Method for preparing (+)R-2-methyl-hexane-1,2-diol |
| GB8617652D0 (en) | 1986-07-18 | 1986-08-28 | Ici Plc | Acylanilide derivatives |
| GB8617653D0 (en) | 1986-07-18 | 1986-08-28 | Ici Plc | Amide derivatives |
| US5162504A (en) | 1988-06-03 | 1992-11-10 | Cytogen Corporation | Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients |
| DK24089D0 (da) * | 1989-01-20 | 1989-01-20 | Hans Bundgaard | Novel prodrug derivatives of biologically active agents containing hydroxyl groups or nh-acidic groups |
| CA2181358A1 (en) | 1994-01-21 | 1995-07-27 | Nancy M. Gray | Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex |
| US5609849A (en) | 1994-03-11 | 1997-03-11 | The Trustees Of The University Of Pennsylvania | Serotonin (5-HT1A) receptor ligands and imaging agents |
| US5656651A (en) | 1995-06-16 | 1997-08-12 | Biophysica Inc. | Androgenic directed compositions |
| US6995284B2 (en) | 2000-08-24 | 2006-02-07 | The University Of Tennessee Research Foundation | Synthesis of selective androgen receptor modulators |
| US6071957A (en) | 1996-11-27 | 2000-06-06 | The University Of Tennessee Research Corporation | Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer |
| US6160011A (en) | 1997-05-30 | 2000-12-12 | The University Of Tennessee Research Corporation | Non-steroidal agonist compounds and their use in male hormone therapy |
| WO1998055153A1 (en) | 1997-06-04 | 1998-12-10 | The University Of Tennessee Research Corporation | Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging |
| GB9918912D0 (en) | 1999-08-12 | 1999-10-13 | Angiogene Pharm Ltd | New stilbenes with vascular damaging activity |
| PL354620A1 (en) | 1999-10-19 | 2004-02-09 | Nobex Corporation | Methods of asymmetrically synthesizing enantiomers of casodex, its derivatives and intermediates thereof |
| JP4520012B2 (ja) * | 1999-10-22 | 2010-08-04 | 武田薬品工業株式会社 | １−置換−１−（１ｈ−イミダゾール−４−イル）メタノール類 |
| IL154425A0 (en) * | 2000-08-24 | 2003-09-17 | Univ Tennessee Res H Corp | Selective androgen receptor modulators and methods of use thereof |
| US7026500B2 (en) | 2000-08-24 | 2006-04-11 | University Of Tennessee Research Foundation | Halogenated selective androgen receptor modulators and methods of use thereof |
| US7547728B2 (en) * | 2001-12-06 | 2009-06-16 | University Of Tennessee Research Foundation | Treating muscle wasting with selective androgen receptor modulators |
| EP1401801B1 (en) | 2000-08-24 | 2006-11-02 | The University Of Tennessee Research Corporation | Selective androgen receptor modulators and methods of use thereof |
| MXPA04008412A (es) * | 2002-02-28 | 2005-05-17 | Univ Tennessee Res Corp | Moduladores irreversibles del receptor de androgeno selectivo y metodos para utilizar los mismos. |
| EP2457892A1 (en) | 2003-01-13 | 2012-05-30 | University of Tennessee Research Foundation | Large-scale synthesis of selective androgen receptor modulators |
| FI20030958A0 (fi) | 2003-06-27 | 2003-06-27 | Orion Corp | Uusia yhdisteitä |
| US20050137172A1 (en) | 2003-10-15 | 2005-06-23 | Dalton James T. | Haloacetamide and azide substituted compounds and methods of use thereof |
-
2004
- 2004-12-16 CA CA002522874A patent/CA2522874A1/en not_active Abandoned
- 2004-12-16 CN CNA2004800165210A patent/CN1805921A/zh active Pending
- 2004-12-16 EA EA200501761A patent/EA200501761A1/ru unknown
- 2004-12-16 US US11/013,214 patent/US7595402B2/en not_active Expired - Fee Related
- 2004-12-16 MX MXPA06000119A patent/MXPA06000119A/es unknown
- 2004-12-16 KR KR1020057022483A patent/KR20060115325A/ko not_active Withdrawn
- 2004-12-16 WO PCT/US2004/042097 patent/WO2005060647A2/en not_active Ceased
- 2004-12-16 TW TW093139204A patent/TW200533636A/zh unknown
- 2004-12-16 JP JP2006545371A patent/JP2007513998A/ja active Pending
- 2004-12-16 EP EP04818029A patent/EP1631540A4/en not_active Withdrawn
- 2004-12-16 AU AU2004305061A patent/AU2004305061A1/en not_active Abandoned
-
2005
- 2005-11-17 IL IL172042A patent/IL172042A0/en unknown
-
2008
- 2008-11-14 AU AU2008243268A patent/AU2008243268A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007513998A5 (https=) | ||
| JP2012505871A5 (https=) | ||
| JP2009506119A5 (https=) | ||
| JP2016537368A5 (https=) | ||
| JP2010506854A5 (https=) | ||
| JP2006511486A5 (https=) | ||
| JP2011522789A5 (https=) | ||
| JP2012515776A5 (https=) | ||
| JP2014528466A5 (https=) | ||
| JP2011513410A5 (https=) | ||
| JP2014528467A5 (https=) | ||
| JP2013502430A5 (https=) | ||
| JP2010511721A5 (https=) | ||
| JP2017137291A5 (https=) | ||
| JP2011519360A5 (https=) | ||
| JP2010511626A5 (https=) | ||
| JP2011529918A5 (https=) | ||
| JP2020506951A5 (https=) | ||
| JP2018533593A5 (https=) | ||
| JP2017528467A5 (https=) | ||
| JP2017505314A5 (https=) | ||
| RU2009117642A (ru) | Применение спирооксиндоловых соединений в качестве терапевтических средств | |
| CA2463569A1 (en) | Activator for peroxisome proliferator-activated receptor .delta. | |
| JP2012508252A5 (https=) | ||
| JP2007508386A5 (https=) |